The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

Inclusion Criteria:

- prostatitis like symptoms for at least three months

Exclusion Criteria:

• significant post-voidal residual volume
• Meares and Stamey test suggestive for bacterial infection
• neoplasms,
• urinary stones,
• antibiotic therapy in the previous three months,
• irritable bowel syndrome,
• previous radiotherapic or chemiotherapic treatment,
• urethral stenosis,
• neurogenic bladder
• previous prostatic surgery